IRIS
DAMANTE, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.642
AS - Asia 9.488
EU - Europa 6.634
SA - Sud America 1.639
Continente sconosciuto - Info sul continente non disponibili 640
AF - Africa 251
OC - Oceania 8
Totale 46.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.186
SG - Singapore 4.365
CN - Cina 1.883
UA - Ucraina 1.475
BR - Brasile 1.264
IT - Italia 1.145
DE - Germania 1.025
HK - Hong Kong 888
VN - Vietnam 788
FI - Finlandia 607
RU - Federazione Russa 597
FR - Francia 408
SE - Svezia 329
IN - India 316
IE - Irlanda 299
GB - Regno Unito 282
TR - Turchia 256
CA - Canada 245
BD - Bangladesh 211
AR - Argentina 139
KR - Corea 104
JP - Giappone 84
IR - Iran 83
IQ - Iraq 81
MX - Messico 79
ZA - Sudafrica 77
BE - Belgio 71
PK - Pakistan 68
EC - Ecuador 66
PL - Polonia 66
NL - Olanda 64
ID - Indonesia 52
SA - Arabia Saudita 49
AT - Austria 48
ES - Italia 47
CO - Colombia 46
VE - Venezuela 36
PH - Filippine 31
CZ - Repubblica Ceca 30
UZ - Uzbekistan 30
EG - Egitto 29
MA - Marocco 28
PY - Paraguay 28
CL - Cile 26
JM - Giamaica 26
KE - Kenya 25
RO - Romania 25
AE - Emirati Arabi Uniti 24
TG - Togo 24
CR - Costa Rica 19
EU - Europa 19
MY - Malesia 19
IL - Israele 16
JO - Giordania 16
RS - Serbia 16
TN - Tunisia 16
UY - Uruguay 16
AZ - Azerbaigian 14
LT - Lituania 14
NP - Nepal 14
BH - Bahrain 12
DO - Repubblica Dominicana 12
DZ - Algeria 12
KZ - Kazakistan 12
LB - Libano 12
TH - Thailandia 12
TT - Trinidad e Tobago 12
GT - Guatemala 10
PA - Panama 10
PS - Palestinian Territory 10
XK - ???statistics.table.value.countryCode.XK??? 10
BG - Bulgaria 9
ET - Etiopia 9
AL - Albania 8
AU - Australia 8
HR - Croazia 8
HU - Ungheria 8
PE - Perù 8
SV - El Salvador 8
CH - Svizzera 7
HN - Honduras 7
GR - Grecia 6
LV - Lettonia 6
PR - Porto Rico 6
PT - Portogallo 6
SN - Senegal 6
TW - Taiwan 6
BO - Bolivia 5
DK - Danimarca 5
OM - Oman 5
BZ - Belize 4
GA - Gabon 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MU - Mauritius 4
AM - Armenia 3
BB - Barbados 3
EE - Estonia 3
LI - Liechtenstein 3
LU - Lussemburgo 3
Totale 45.624
Salva come PNG Salva come JPEG
Città #
Fairfield 2.754
Ashburn 2.429
Woodbridge 2.056
Singapore 1.949
Chandler 1.411
Houston 1.411
San Jose 1.279
Seattle 1.186
Ann Arbor 1.107
Wilmington 1.037
Jacksonville 971
Cambridge 956
Beijing 884
Hong Kong 879
Council Bluffs 701
Dearborn 626
Los Angeles 489
Chicago 466
Boardman 414
Udine 317
Lauterbourg 307
New York 300
Dublin 294
Princeton 278
Ho Chi Minh City 262
Munich 200
Salt Lake City 196
Izmir 187
Buffalo 186
Dallas 164
The Dalles 159
Phoenix 151
Santa Clara 150
Hanoi 140
San Diego 136
Hefei 133
São Paulo 128
Helsinki 110
Ogden 95
Seoul 95
Tampa 92
Redmond 88
Redondo Beach 88
Milan 87
Des Moines 86
Elk Grove Village 84
Frankfurt am Main 83
Dong Ket 73
Turku 73
Tokyo 72
Norwalk 70
Brussels 66
Montreal 65
Sterling 60
Columbus 59
Atlanta 58
Mumbai 58
Orem 57
Toronto 56
Warsaw 56
Trieste 55
Denver 51
Brooklyn 50
Pittsburgh 48
Rio de Janeiro 48
Augusta 47
San Mateo 47
Ottawa 46
Chennai 45
Johannesburg 44
Kunming 44
Lancaster 44
Rome 42
Washington 42
London 40
Leawood 39
Baghdad 38
Miami 37
Düsseldorf 36
Stockholm 36
Belo Horizonte 35
Nanjing 35
Poplar 35
Falls Church 33
Grafing 33
Nuremberg 33
Ardabil 31
Da Nang 31
Amsterdam 30
Guangzhou 30
Kansas City 30
Mexico City 30
San Francisco 30
Vienna 28
Boston 27
Brasília 27
Tashkent 27
Ankara 26
Detroit 24
Lomé 24
Totale 29.902
Salva come PNG Salva come JPEG
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.112
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 497
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 351
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 283
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 238
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 230
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 229
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 229
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 228
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 228
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 217
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 215
Expression of periostin in human breast cancer 215
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 214
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 212
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 211
Expression of differentiation markers in cultured cells from various thyroid diseases 209
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 208
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 207
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 204
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 201
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 201
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 201
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 199
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 199
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 198
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 197
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 196
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 196
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 195
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 195
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 194
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 194
Galectin-3 expression in non-small cell lung carcinoma 193
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 192
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 192
A molecular code dictates sequence-specific DNA recognition by homeodomains 192
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 191
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 189
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 189
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 188
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 188
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 188
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 187
Histone post-translational modifications associated to BAALC expression in leukemic cells. 186
A differential proteomic approach to identify proteins associated with thyroid cell transformation 185
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 184
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 184
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 183
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 183
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 183
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 182
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 181
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 181
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 180
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 179
Nucleophosmin is overexpressed in thyroid tumors 179
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 178
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 178
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 178
PAX8 expression in human bladder cancer. 176
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics 175
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 175
Homology model building of the thyroid transcription factor 1 homeodomain 173
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 173
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 173
A CGH array procedure to detect PAX6 gene structural defects 172
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 171
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 171
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 170
Molecular events in the differentiation of the thyroid gland 170
Differential proteomic analysis of nuclear extracts from thyroid cell lines 170
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 169
Blood-brain barrier dysfunction in disorders of the developing brain 168
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 167
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 166
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 166
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 166
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 164
TSH controls ref-1 nuclear translocation in thyroid cells 164
A simple multiplex real-time PCR methodology for the SMN1 gene copy number quantification 163
Thyroid-specific gene expression. 162
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 162
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 162
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. 162
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 162
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 162
An 'environment to nucleus' signaling system operates in B lymphocytes: redox status 162
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 161
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 161
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 161
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 160
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 159
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 159
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 159
Unexpected phenotype of a typical NPM1 mutant 158
Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer 157
Mitochondrial localization of APE/Ref-1 in thyroid cells 157
In vitro cultures of pathological thyroid cells: a powerful diagnostic technique 156
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 156
Totale 19.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.208 0 0 0 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/202613.762 1.362 2.339 996 1.272 1.789 925 1.493 338 907 1.027 768 546
2026/20272.484 264 747 1.038 435 0 0 0 0 0 0 0 0
Totale 46.302